The genetics of splicing in neuroblastoma.
暂无分享,去创建一个
Pui-Yan Kwok | Javed Khan | Jun S. Song | Jun S Song | Annette M Molinaro | Allan Balmain | William A Weiss | Justin Chen | P. Kwok | A. Balmain | J. Khan | J. Costello | A. Molinaro | T. van Dyke | T. Dyke | W. Weiss | Justin Chen | D. Quigley | W. C. Gustafson | Young K. Song | Shile Zhang | Christopher S Hackett | Shile Zhang | Young K Song | Robert J A Bell | David A Quigley | Joseph F Costello | W Clay Gustafson | Terry Van Dyke | Robert J. A. Bell | Christopher S. Hackett | W. Gustafson
[1] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[2] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[3] M. Peters,et al. Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.
[4] Zefeng Wang,et al. Intronic Splicing Enhancers, Cognate Splicing Factors and Context Dependent Regulation Rules , 2012, Nature Structural &Molecular Biology.
[5] Joseph K. Pickrell,et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing , 2010, Nature.
[6] L. Liotta,et al. A Transforming Growth Factor-β Receptor–Interacting Protein Frequently Mutated in Human Ovarian Cancer , 2005 .
[7] M. Garcia-Blanco,et al. Alternative splicing in disease and therapy , 2004, Nature Biotechnology.
[8] Mark I. McCarthy,et al. Identification of an imprinted master trans-regulator at the KLF14 locus related to multiple metabolic phenotypes , 2011, Nature Genetics.
[9] Thomas M. Keane,et al. Sequencing and characterization of the FVB/NJ mouse genome , 2012, Genome Biology.
[10] D. Zwijnenburg,et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.
[11] Jacek Majewski,et al. Genome-wide analysis of transcript isoform variation in humans , 2008, Nature Genetics.
[12] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[13] J. Valcárcel,et al. The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.
[14] H. Fraser,et al. Common polymorphic transcript variation in human disease. , 2009, Genome research.
[15] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[16] Frequent Pathway Mutations of Splicing Machinery in Myelodysplasia , 2011 .
[17] Hiroki Nagase,et al. Genetic architecture of murine skin inflammation and tumor susceptibility , 2016 .
[18] Rolf Backofen,et al. Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.
[19] Tatiana Popova,et al. Supplementary Methods , 2012, Acta Neuropsychiatrica.
[20] Brendan J. Frey,et al. A compendium of RNA-binding motifs for decoding gene regulation , 2013, Nature.
[21] G. Clore,et al. Structure and dynamics of KH domains from FBP bound to single-stranded DNA , 2002, Nature.
[22] J. Khan,et al. Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status , 2011, BMC Medical Genomics.
[23] Jinghui Zhang,et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. , 2012, JAMA.
[24] L. Liotta,et al. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer. , 2005, Cancer research.
[25] A. Inoue,et al. RBM10 regulates alternative splicing , 2014, FEBS letters.
[26] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Chen,et al. Alternative splicing in cancer: implications for biology and therapy , 2014, Oncogene.
[28] Mikael Bodén,et al. MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..
[29] K. Shianna,et al. Tissue-Specific Genetic Control of Splicing: Implications for the Study of Complex Traits , 2008, PLoS biology.
[30] M. Schwab,et al. Suppression of MYC by high expression of NMYC in human neuroblastoma cells , 1989, Journal of neuroscience research.
[31] Antonio Ortega,et al. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. , 2006, Journal of the National Cancer Institute.
[32] D. Koller,et al. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals , 2013, Genome research.
[33] P. Schirmacher,et al. Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells , 2009, Hepatology.
[34] A. Look,et al. Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group , 2013, Cancer.
[35] Henning Urlaub,et al. Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD‐box protein , 2002, The EMBO journal.
[36] C. Gissi,et al. Assessment of orthologous splicing isoforms in human and mouse orthologous genes , 2010, BMC Genomics.
[37] J. Doudna,et al. Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma , 2011 .
[38] H. Hakonarson,et al. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. , 2012, Cancer research.
[39] P. Cahan,et al. Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. , 2011, The Journal of clinical investigation.
[40] J. Buizer-Voskamp,et al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. , 2008, American journal of human genetics.
[41] Chandra Sekhar Pedamallu,et al. A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events , 2014, PloS one.
[42] Steven P. Gygi,et al. Comprehensive proteomic analysis of the human spliceosome , 2002, Nature.
[43] William A Weiss,et al. Neuroblastoma and MYCN. , 2013, Cold Spring Harbor perspectives in medicine.
[44] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[45] J. Uhm. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .
[46] L. Kruglyak,et al. Genetic Dissection of Transcriptional Regulation in Budding Yeast , 2002, Science.
[47] Nikolaus Grigorieff,et al. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. , 2002, RNA.
[48] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[49] R. Guigó,et al. Transcriptome genetics using second generation sequencing in a Caucasian population , 2010, Nature.
[50] G. Mohapatra,et al. Targeted expression of MYCN causes neuroblastoma in transgenic mice , 1997, The EMBO journal.
[51] K. M. Mulder,et al. A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein. , 2002, Molecular biology of the cell.
[52] N. Awasthi,et al. Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II , 2012, PloS one.
[53] D. Levens,et al. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. , 1994, Genes & development.
[54] Christopher B. Burge,et al. Alternative Splicing of RNA Triplets Is Often Regulated and Accelerates Proteome Evolution , 2012, PLoS biology.
[55] David Levens,et al. FBPs Are Calibrated Molecular Tools To Adjust Gene Expression , 2006, Molecular and Cellular Biology.
[56] Harry Zuzan,et al. Heritability of alternative splicing in the human genome. , 2007, Genome research.